Identification of genomic biomarkers for oral cancers in Indian patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- This study will provide genomic information about Indian patients with oral cancers. This will
Study Overview
Brief Summary
In recent years, genomic data is being captured for various cancers, this has allowed better understanding of the genomic variations in the patients. This has potential to help in personalizing treatment.There is limited data available regarding genomic variation of oral cancers. Major data which is available is from Western countries. There have only been a few studies which have evaluated this in Indian cohorts. The genomic data can help us understand which lesions can progress to malignancy, where there will be higher chances of recurrences, detecting such recurrences early, predicting treatment outcomes and thus being able to personalize therapies
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 80.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Oral cancer Undergoing curative resection Stages I-IV.
Exclusion Criteria
- •Prior chemo/radiotherapy Previous cancer Not giving consent.
Outcomes
Primary Outcomes
This study will provide genomic information about Indian patients with oral cancers. This will
Time Frame: We propose to start this study by August 2025 and hope to finish within 24 months
help us in developing targeted diagnostic platforms and help in tailoring theranostic
Time Frame: We propose to start this study by August 2025 and hope to finish within 24 months
modalities.
Time Frame: We propose to start this study by August 2025 and hope to finish within 24 months
Secondary Outcomes
No secondary outcomes reported
Investigators
Dr Akshat Malik
Max Super speciality Hospital East Block, A unit of Devki Devi Foundation